A position statement on the post gene-therapy rehabilitation of aromatic I-amino acid decarboxylase deficiency patients.
AADC deficiency
Fine motor development
Gene therapy
Gross motor development
Neurotransmitter disorder
Physical therapy
Rehabilitation outcomes
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
18 Jan 2024
18 Jan 2024
Historique:
received:
17
01
2023
accepted:
11
01
2024
medline:
19
1
2024
pubmed:
19
1
2024
entrez:
18
1
2024
Statut:
epublish
Résumé
Aromatic L-amino acid decarboxylase (AADC) deficiency is a rare genetic disorder of monoamine neurotransmitter synthesis that presents with a range of symptoms, including motor dysfunction and limited attainment of developmental motor milestones. The approval of eladocagene exuparvovec, a gene therapy for AADC deficiency with demonstrated efficacy for motor improvements, now expands the range of motor outcomes possible for patients with this disorder. However, recommendations and guidelines for therapy following treatment with gene therapy are lacking. To ensure patients can reach their full potential following treatment with gene therapy, it is essential they receive rehabilitation therapies designed specifically with their impairments and goals in mind. Therefore, we highlight specific rehabilitative needs of patients following gene therapy and propose a set of recommendations for the post-treatment period based on collective experiences of therapists, physicians, and caregivers treating and caring for patients with AADC deficiency who have been treated with gene therapy. These recommendations include a focus on periods of intensive therapy, facilitating active movements, training for functional abilities, cognitive and communication training, parent/caregiver empowerment, collaboration between therapists and caregivers to develop in-home programs, and the incorporation of supplemental forms of therapy that patients and their families may find more enjoyable and engaging. Many of these rehabilitative strategies may be employed prior to gene therapy. However, these recommendations will be valuable for therapists, caregivers, and wider treatment teams as they prepare for the post-treatment journey with these patients. Furthermore, the considerations and recommendations presented here may prove beneficial outside the AADC deficiency community as gene therapies and other treatments are developed and approved for other rare diseases.
Identifiants
pubmed: 38238766
doi: 10.1186/s13023-024-03019-x
pii: 10.1186/s13023-024-03019-x
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
17Informations de copyright
© 2024. The Author(s).
Références
OMIM. Aromatic L-amino acid decarboxylase deficiency; AADCD. Accessed 4 Nov 2022. https://www.omim.org/entry/608643
BRENDA. Information on EC 4.1.1.28 -aromatic-L-amino-acid decarboxylase. Accessed 4 Nov 2022. https://www.brenda-enzymes.org/enzyme.php?ecno=4.1.1.28
Himmelreich N, Montioli R, Bertoldi M, et al. Aromatic amino acid decarboxylase deficiency: molecular and metabolic basis and therapeutic outlook. Mol Genet Metab. 2019;127(1):12–22. https://doi.org/10.1016/j.ymgme.2019.03.009 .
doi: 10.1016/j.ymgme.2019.03.009
pubmed: 30952622
Wassenberg T, Molero-Luis M, Jeltsch K, et al. Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency. Orphanet J Rare Dis. 2017;12(1):12. https://doi.org/10.1186/s13023-016-0522-z .
doi: 10.1186/s13023-016-0522-z
pubmed: 28100251
pmcid: 5241937
Brun L, Ngu LH, Keng WT, et al. Clinical and biochemical features of aromatic L-amino acid decarboxylase deficiency. Neurology. 2010;75(1):64–71. https://doi.org/10.1212/WNL.0b013e3181e620ae .
doi: 10.1212/WNL.0b013e3181e620ae
pubmed: 20505134
Swoboda KJ, Saul JP, McKenna CE, Speller NB, Hyland K. Aromatic L-amino acid decarboxylase deficiency: overview of clinical features and outcomes. Ann Neurol. 2003;54(Suppl 6):S49-55. https://doi.org/10.1002/ana.10631 .
doi: 10.1002/ana.10631
pubmed: 12891654
Pearson TS, Gilbert L, Opladen T, et al. AADC deficiency from infancy to adulthood: symptoms and developmental outcome in an international cohort of 63 patients. J Inherit Metab Dis. 2020;43(5):1121–30. https://doi.org/10.1002/jimd.12247 .
doi: 10.1002/jimd.12247
pubmed: 32369189
pmcid: 7540529
Williams K, Skrobanski H, Werner C, O’Neill S, Buesch K, Acaster S. Symptoms and impact of aromatic l-amino acid decarboxylase (AADC) deficiency: a qualitative study and the development of a patient-centred conceptual model. Curr Med Res Opin. 2021;37(8):1353–61. https://doi.org/10.1080/03007995.2021.1932449 .
doi: 10.1080/03007995.2021.1932449
pubmed: 34042550
Wang H, Li J, Zhou J, et al. Oculogyric crisis mimicked epilepsy in a Chinese aromatic L-amino acid decarboxylase-deficiency patient: A case report. Front Neurol. 2022;13: 919583. https://doi.org/10.3389/fneur.2022.919583 .
doi: 10.3389/fneur.2022.919583
pubmed: 36119679
pmcid: 9481412
PTC Therapeutics. Upstaza™ granted marketing authorization by European Commission as first disease-modifying treatment for AADC deficiency. July 20, 2022. Accessed 4 Nov 2022. https://www.prnewswire.com/news-releases/upstaza-granted-marketing-authorization-by-european-commission-as-first-disease-modifying-treatment-for-aadc-deficiency-301589884.html#:~:text=Upstaza%20is%20the%20first%20approved,patients%2018%20months%20and%20older . 2022.
PTC Therapeutics I. Upstaza™ gene therapy granted marketing authorization for AADC deficiency by UK's MHRA. November 17, 2022. Accessed 5 Dec 2022. https://www.prnewswire.com/news-releases/upstaza-gene-therapy-granted-marketing-authorization-for-aadc-deficiency-by-uks-mhra-301681531.html . 2022.
Upstaza. Summary of product characteristics. PTC Therapeutics, Inc. 2022.
Tai CH, Lee NC, Chien YH, et al. Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency. Mol Ther. 2022;30(2):509–18. https://doi.org/10.1016/j.ymthe.2021.11.005 .
doi: 10.1016/j.ymthe.2021.11.005
pubmed: 34763085
Sanger WG, Dave B, Stuberg W. Overview of genetics and role of the pediatric physical therapist in the diagnostic process. Pediatr Phys Ther. 2001;13(4):164–8.
doi: 10.1097/00001577-200112000-00003
pubmed: 17053634
Shurtleff TL, Engsberg JR. Changes in trunk and head stability in children with cerebral palsy after hippotherapy: a pilot study. Phys Occup Ther Pediatr. 2010;30(2):150–63. https://doi.org/10.3109/01942630903517223 .
doi: 10.3109/01942630903517223
pubmed: 20367519
Santonja-Medina CS, Marrades-Caballero E, Santonja-Medina F, Sanz-Mengibar JM. Neurologic music therapy improves participation in children with severe cerebral palsy. Front Neurol. 2022;13:795533. https://doi.org/10.3389/fneur.2022.795533 .
doi: 10.3389/fneur.2022.795533
pubmed: 35356462
pmcid: 8959457
Romero-Ayuso D, Ruiz-Salcedo M, Barrios-Fernández S, et al. Play in children with neurodevelopmental disorders: psychometric properties of a parent report measure “My Child’s Play.” Children (Basel). 2021. https://doi.org/10.3390/children8010025 .
doi: 10.3390/children8010025
pubmed: 34200660
pmcid: 8535573
Nijhof SL, Vinkers CH, van Geelen SM, et al. Healthy play, better coping: the importance of play for the development of children in health and disease. Neurosci Biobehav Rev. 2018;95:421–9. https://doi.org/10.1016/j.neubiorev.2018.09.024 .
doi: 10.1016/j.neubiorev.2018.09.024
pubmed: 30273634
Lotan M, Elefant C. Rett syndrome: dual intervention - music and physical therapy. Nord J Music Ther. 2004;13:172–82. https://doi.org/10.1080/08098130409478114 .
doi: 10.1080/08098130409478114
Escobar Torres L, Sanders ME, Belenguer Benitez C, Melendez OA. Efficacy of an aquatic exercise program for 3 cases of Rett syndrome. Pediatr Phys Ther. 2019;31(4):E6-e13. https://doi.org/10.1097/pep.0000000000000655 .
doi: 10.1097/pep.0000000000000655
pubmed: 31568388
Onuki Y, Ono S, Nakajima T, et al. Dopaminergic restoration of prefrontal cortico-putaminal network in gene therapy for aromatic l-amino acid decarboxylase deficiency. Brain Commun. 2021;3(3):fcab078. https://doi.org/10.1093/braincomms/fcab078 .
doi: 10.1093/braincomms/fcab078
pubmed: 34423296
pmcid: 8374966
Christy JB, Saleem N, Turner PH, Wilson J. Parent and therapist perceptions of an intense model of physical therapy. Pediatr Phys Ther. 2010;22(2):207–13. https://doi.org/10.1097/PEP.0b013e3181db8151 .
doi: 10.1097/PEP.0b013e3181db8151
pubmed: 20473106
Arpino C, Vescio MF, De Luca A, Curatolo P. Efficacy of intensive versus nonintensive physiotherapy in children with cerebral palsy: a meta-analysis. Int J Rehabil Res. 2010;33(2):165–71. https://doi.org/10.1097/MRR.0b013e328332f617 .
doi: 10.1097/MRR.0b013e328332f617
pubmed: 19910797
Shamir M, Dickstein R, Tirosh E. Intensive intermittent physical therapy in infants with cerebral palsy: a randomized controlled pilot study. Isr Med Assoc J. 2012;14(12):737–41.
pubmed: 23393711
Trahan J, Malouin F. Intermittent intensive physiotherapy in children with cerebral palsy: a pilot study. Dev Med Child Neurol. 2002;44(4):233–9. https://doi.org/10.1017/s0012162201002006 .
doi: 10.1017/s0012162201002006
pubmed: 11995891
Alternating Hemiplegia of Childhood Foundation. Intensive model of therapy (IMOT). Accessed 4 Nov 2022. http://ahckids.org/resources/intensive-model-of-therapy-imot/
Hwu P, Wang A, Russell A, Turna J, Tai C. Early clinical improvements following treatment with eladocagene exuparvovec in patients with aromatic L amino acid decarboxylase deficiency. Poster presented at: International Symposium on Paediatric Movement Disorders; February 9–11, 2022.
Sakzewski L, Ziviani J, Boyd RN. Efficacy of upper limb therapies for unilateral cerebral palsy: a meta-analysis. Pediatrics. 2014;133(1):e175-204. https://doi.org/10.1542/peds.2013-0675 .
doi: 10.1542/peds.2013-0675
pubmed: 24366991
Myrhaug H, Østensjø S, Larun L, Odgaard-Jensen J, Jahnsen R. Intensive training of motor function and functional skills among young children with cerebral palsy: a systematic review and meta-analysis. BMC Pediatr. 2014;14:292. https://doi.org/10.1186/s12887-014-0292-5 .
doi: 10.1186/s12887-014-0292-5
Lillo-Navarro C, Medina-Mirapeix F, Escolar-Reina P, Montilla-Herrador J, Gomez-Arnaldos F, Oliveira-Sousa SL. Parents of children with physical disabilities perceive that characteristics of home exercise programs and physiotherapists’ teaching styles influence adherence: a qualitative study. J Physiother. 2015;61(2):81–6. https://doi.org/10.1016/j.jphys.2015.02.014 .
doi: 10.1016/j.jphys.2015.02.014
pubmed: 25804826
Novak I. Parent experience of implementing effective home programs. Phys Occup Ther Pediatr. 2011;31(2):198–213. https://doi.org/10.3109/01942638.2010.533746 .
doi: 10.3109/01942638.2010.533746
pubmed: 21121708
McCoy SW, Palisano R, Avery L, et al. Physical, occupational, and speech therapy for children with cerebral palsy. Dev Med Child Neurol. 2020;62(1):140–6. https://doi.org/10.1111/dmcn.14325 .
doi: 10.1111/dmcn.14325
pubmed: 31353456
Hall JB, Woods ML, Luechtefeld JT. Pediatric physical therapy telehealth and COVID-19: factors, facilitators, and barriers influencing effectiveness-a survey study. Pediatr Phys Ther. 2021;33(3):112–8. https://doi.org/10.1097/pep.0000000000000800 .
doi: 10.1097/pep.0000000000000800
pubmed: 34086621
Cottrell MA, Galea OA, O’Leary SP, Hill AJ, Russell TG. Real-time telerehabilitation for the treatment of musculoskeletal conditions is effective and comparable to standard practice: a systematic review and meta-analysis. Clin Rehabil. 2017;31(5):625–38. https://doi.org/10.1177/0269215516645148 .
doi: 10.1177/0269215516645148
pubmed: 27141087
Piek JP. The contribution of spontaneous movements in the acquisition of motor coordination in infants. In: Glencross DJ, Piek JP, editors. Advances in psychology. North-Holland; 1995. p. 199–230.
WHO Motor Development Study. windows of achievement for six gross motor development milestones. Acta Paediatr Suppl. 2006;450:86–95. https://doi.org/10.1111/j.1651-2227.2006.tb02379.x .
doi: 10.1111/j.1651-2227.2006.tb02379.x
Abdel-Rahman SA, Elsaied S, Elshamy M, Mohamed S, El-Dien N. Effectiveness of play therapy on gross manual dexterity in children with hemiparetic cerebral palsy. IJRAMR. 2022;6(2):4637–41.
Pitroda N, Sethi J. The effect of play therapy over conventional therapy in improving the hand function of spastic diplegic cerebral palsy children. Indian J Physiother Occup Ther. 2008;2:8–15.
Kratz SV. Sensory integration intervention: historical concepts, treatment strategies and clinical experiences in three patients with succinic semialdehyde dehydrogenase (SSADH) deficiency. J Inherit Metab Dis. 2009;32(3):353–60. https://doi.org/10.1007/s10545-009-1149-1 .
doi: 10.1007/s10545-009-1149-1
pubmed: 19381864
Kantor J, Hlaváčková L, Du J, et al. The effects of Ayres sensory integration and related sensory based interventions in children with cerebral palsy: a scoping review. Children. 2022. https://doi.org/10.3390/children9040483 .
doi: 10.3390/children9040483
pubmed: 35455527
pmcid: 9032213
Paleg GS, Smith BA, Glickman LB. Systematic review and evidence-based clinical recommendations for dosing of pediatric supported standing programs. Pediatr Phys Ther. 2013;25(3):232–47. https://doi.org/10.1097/PEP.0b013e318299d5e7 .
doi: 10.1097/PEP.0b013e318299d5e7
pubmed: 23797394
Bunge LR, Davidson AJ, Helmore BR, et al. Effectiveness of powered exoskeleton use on gait in individuals with cerebral palsy: a systematic review. PLoS ONE. 2021;16(5): e0252193. https://doi.org/10.1371/journal.pone.0252193 .
doi: 10.1371/journal.pone.0252193
pubmed: 34038471
pmcid: 8153467
Marrades-Caballero E, Santonja-Medina CS, Sanz-Mengibar JM, Santonja-Medina F. Neurologic music therapy in upper-limb rehabilitation in children with severe bilateral cerebral palsy: a randomized controlled trial. Eur J Phys Rehabil Med. 2018;54(6):866–72. https://doi.org/10.23736/s1973-9087.18.04996-1 .
doi: 10.23736/s1973-9087.18.04996-1
pubmed: 29484877
Champagne D, Dugas C. Improving gross motor function and postural control with hippotherapy in children with Down syndrome: case reports. Physiother Theory Pract. 2010;26(8):564–71. https://doi.org/10.3109/09593981003623659 .
doi: 10.3109/09593981003623659
pubmed: 20673078
Huguet-Rodríguez M, Arias-Buría JL, Huguet-Rodríguez B, Blanco-Barrero R, Braña-Sirgo D, Güeita-Rodríguez J. Impact of aquatic exercise on respiratory outcomes and functional activities in children with neuromuscular disorders: findings from an open-label and prospective preliminary pilot study. Brain Sci. 2020. https://doi.org/10.3390/brainsci10070458 .
doi: 10.3390/brainsci10070458
pubmed: 32708972
pmcid: 7407397
Crocker LD, Heller W, Warren SL, O’Hare AJ, Infantolino ZP, Miller GA. Relationships among cognition, emotion, and motivation: implications for intervention and neuroplasticity in psychopathology. Front Hum Neurosci. 2013;7:261. https://doi.org/10.3389/fnhum.2013.00261 .
doi: 10.3389/fnhum.2013.00261
pubmed: 23781184
pmcid: 3678097
Braver TS, Krug MK, Chiew KS, et al. Mechanisms of motivation-cognition interaction: challenges and opportunities. Cogn Affect Behav Neurosci. 2014;14(2):443–72. https://doi.org/10.3758/s13415-014-0300-0 .
doi: 10.3758/s13415-014-0300-0
pubmed: 24920442
pmcid: 4986920
Beukelman DR, Light JC. Augmentative and alternative communication processes for children and adults with complex communication needs. Augmentative & Alternative Communication. Paul Brookes; 2020. p. 3–15.
TalkTools. What is OPT? Accessed 4 Nov 2022. https://talktools.com/pages/what-is-opt#:~:text=Oral%20Placement%20Therapy%20is%20a,with%20placement%20and%20movement%20deficits
Gosa MM, Dodrill P, Lefton-Greif MA, Silverman A. A multidisciplinary approach to pediatric feeding disorders: roles of the speech-language pathologist and behavioral psychologist. Am J Speech Lang Pathol. 2020;29(2s):956–66. https://doi.org/10.1044/2020_ajslp-19-00069 .
doi: 10.1044/2020_ajslp-19-00069
pubmed: 32650658
Skrobanski H, Williams K, Werner C, O’Neill S, Buesch K, Acaster S. The impact of caring for an individual with aromatic l-amino acid decarboxylase (AADC) deficiency: a qualitative study and the development of a conceptual model. Curr Med Res Opin. 2021;37(10):1821–8. https://doi.org/10.1080/03007995.2021.1955668 .
doi: 10.1080/03007995.2021.1955668
pubmed: 34259573
Centers for Disease Control and Prevention. Concerned about your childs development? Accessed 4 Nov 2022. https://www.cdc.gov/ncbddd/actearly/concerned.html
Ontario. Infant child development program. Accessed 4 Nov 2022. https://www.ontario.ca/page/infant-child-development-program
Ontario. Children with special needs. Accessed 4 Nov 2022. https://www.ontario.ca/page/children-special-needs
British Columbia. Early childhood intervention programs. Accessed 4 Nov 2022. https://www2.gov.bc.ca/gov/content/health/managing-your-health/child-behaviour-development/assessing-child-development-38610
Kuo HT, Muo CH, Chang YT, Lin CK. Change in prevalence status for children with developmental delay in Taiwan: a nationwide population-based retrospective study. Neuropsychiatr Dis Treat. 2015;11:1541–7. https://doi.org/10.2147/ndt.S84088 .
doi: 10.2147/ndt.S84088
pubmed: 26203248
pmcid: 4487160
Adolph KE, Franchak JM. The development of motor behavior. Wiley Interdiscip Rev Cogn Sci. 2017. https://doi.org/10.1002/wcs.1430 .
doi: 10.1002/wcs.1430
pubmed: 27906517
O'Donnell M. HIP surveillance: bottom line ‘evidence-informed’ recommendations for the HIP surveillance in individuals with cerebral palsy. 2017. Accessed 4 Nov 2022. https://www.aacpdm.org/UserFiles/file/hip-surveillance-care-pathway.pdf . 2017; p. 1–3.
Findley PA. Social work practice in the chronic care model: chronic illness and disability care. J Soc Work. 2014;14(1):83–95. https://doi.org/10.1177/1468017313475381 .
doi: 10.1177/1468017313475381
Bergman AS, Lewiston NJ, West AM. Social work practice and chronic pediatric illness. Soc Work Health Care. 1979;4(3):265–74. https://doi.org/10.1300/J010v04n03_02 .
doi: 10.1300/J010v04n03_02
Jones K, Hawke F, Newman J, et al. Interventions for promoting physical activity in people with neuromuscular disease. Cochrane Database Syst Rev. 2021;5(5):Cd013544. https://doi.org/10.1002/14651858.CD013544.pub2 .
doi: 10.1002/14651858.CD013544.pub2
pubmed: 34027632
Leuzzi V, Mastrangelo M, Polizzi A, et al. Report of two never treated adult sisters with aromatic L-amino acid decarboxylase deficiency: a portrait of the natural history of the disease or an expanding phenotype? JIMD Rep. 2015;15:39–45. https://doi.org/10.1007/8904_2014_295 .
doi: 10.1007/8904_2014_295
pubmed: 24788355
Bailes AF, Reder R, Burch C. Development of guidelines for determining frequency of therapy services in a pediatric medical setting. Pediatr Phys Ther. 2008;20(2):194–8. https://doi.org/10.1097/PEP.0b013e3181728a7b .
doi: 10.1097/PEP.0b013e3181728a7b
pubmed: 18480720
Academy of Pediatric Physical Therapy. Intensity of service in an outpatient setting for children with chronic conditions: fact sheet. American Physical Therapy Association. 2012.
American Physical Therapy Association. Standards of practice for physical therapy: fact sheet. 2020. American Physical Therapy Association.
Folio MR, Fewell RR. Peabody developmental motor scales: Examiner's Guide. 2nd ed. Pro-Ed; 2000.
Provost B, Heimerl S, McClain C, Kim NH, Lopez BR, Kodituwakku P. Concurrent validity of the Bayley Scales of Infant Development II Motor Scale and the Peabody Developmental Motor Scales-2 in children with developmental delays. Pediatr Phys Ther. 2004;16(3):149–56. https://doi.org/10.1097/01.Pep.0000136005.41585.Fe .
doi: 10.1097/01.Pep.0000136005.41585.Fe
pubmed: 17057542
Piper M, Darrah J, eds. Alberta Infant Motor Scale: construction of a motor assessment tool for the developing infant. In: Motor assessment of the developing infant. Saunders; 1994, p. 25–35